SREBF1 and metabolic dysfunction-associated steatotic liver disease: Studies have demonstrated that NOB alleviates lipid accumulation, oxidative stress, and inflammatory responses in NAFLD by regulating key signaling pathways, including Nrf2, SREBP-1c, and NF-κB [23].